Magnetic resonance imaging and spectroscopic imaging of prostate cancer

Fergus V. Coakley, Aliya Qayyum, John Kurhanewicz, Philip W. Kantoff, Fergus Coakley, Peter R. Carroll, Mack Roach, Matthew R. Smith, William K. Oh

Research output: Contribution to journalArticle

119 Citations (Scopus)

Abstract

Purpose: We describe the practical technical aspects of magnetic resonance spectroscopic imaging (MRSI), and summarize the current and potential future status of magnetic resonance imaging (MRI) and MRSI in the diagnosis, localization, staging, treatment planning and posttreatment followup of prostate cancer. Materials and Methods: Contemporary series of patients with prostate cancer evaluated by MRI and MRSI were reviewed, with particular respect to imaging accuracy as evaluated by histopathological correlation, and the relationship between MRI and MRSI and outcome. Results: MRI and MRSI have a limited role in prostate cancer diagnosis but may be helpful for patients with a high index of suspicion and negative initial biopsy. High specificity can be achieved for sextant localization of cancer when sextant biopsy, MRI and MRSI are all positive. Volumetric localization is of limited accuracy for tumors less than 0.5 cc. Staging by MRI, which is improved by the addition of MRSI, is of incremental prognostic significance for patients with moderate and high risk tumors. MRI and MRSI may assist in surgical and radiation treatment planning, and posttreatment followup. In particular, the use of MRI to assist radiation treatment planning has been shown to improve outcome. Interventional MRI guided biopsy and therapy remain under investigation. Conclusions: Only MRI and MRSI allow combined structural and metabolic evaluation of prostate cancer location, aggressiveness and stage. MRI provides clinically and therapeutically relevant anatomical information. The technology remains in evolution, and continued advances in accuracy and use are likely.

Original languageEnglish (US)
JournalJournal of Urology
Volume170
Issue number6 II
DOIs
StatePublished - Dec 2003
Externally publishedYes

Fingerprint

Prostatic Neoplasms
Magnetic Resonance Imaging
Interventional Magnetic Resonance Imaging
Image-Guided Biopsy
Radiation
Biopsy
Neoplasms
Therapeutics

Keywords

  • Magnetic resonance imaging
  • Magnetic resonance spectroscopy
  • Prostatic neoplasms

ASJC Scopus subject areas

  • Urology

Cite this

Coakley, F. V., Qayyum, A., Kurhanewicz, J., Kantoff, P. W., Coakley, F., Carroll, P. R., ... Oh, W. K. (2003). Magnetic resonance imaging and spectroscopic imaging of prostate cancer. Journal of Urology, 170(6 II). https://doi.org/10.1097/01.ju.0000094958.23276.c4

Magnetic resonance imaging and spectroscopic imaging of prostate cancer. / Coakley, Fergus V.; Qayyum, Aliya; Kurhanewicz, John; Kantoff, Philip W.; Coakley, Fergus; Carroll, Peter R.; Roach, Mack; Smith, Matthew R.; Oh, William K.

In: Journal of Urology, Vol. 170, No. 6 II, 12.2003.

Research output: Contribution to journalArticle

Coakley, FV, Qayyum, A, Kurhanewicz, J, Kantoff, PW, Coakley, F, Carroll, PR, Roach, M, Smith, MR & Oh, WK 2003, 'Magnetic resonance imaging and spectroscopic imaging of prostate cancer', Journal of Urology, vol. 170, no. 6 II. https://doi.org/10.1097/01.ju.0000094958.23276.c4
Coakley, Fergus V. ; Qayyum, Aliya ; Kurhanewicz, John ; Kantoff, Philip W. ; Coakley, Fergus ; Carroll, Peter R. ; Roach, Mack ; Smith, Matthew R. ; Oh, William K. / Magnetic resonance imaging and spectroscopic imaging of prostate cancer. In: Journal of Urology. 2003 ; Vol. 170, No. 6 II.
@article{3aef0e30b3a34a8480fe4234b082ffbf,
title = "Magnetic resonance imaging and spectroscopic imaging of prostate cancer",
abstract = "Purpose: We describe the practical technical aspects of magnetic resonance spectroscopic imaging (MRSI), and summarize the current and potential future status of magnetic resonance imaging (MRI) and MRSI in the diagnosis, localization, staging, treatment planning and posttreatment followup of prostate cancer. Materials and Methods: Contemporary series of patients with prostate cancer evaluated by MRI and MRSI were reviewed, with particular respect to imaging accuracy as evaluated by histopathological correlation, and the relationship between MRI and MRSI and outcome. Results: MRI and MRSI have a limited role in prostate cancer diagnosis but may be helpful for patients with a high index of suspicion and negative initial biopsy. High specificity can be achieved for sextant localization of cancer when sextant biopsy, MRI and MRSI are all positive. Volumetric localization is of limited accuracy for tumors less than 0.5 cc. Staging by MRI, which is improved by the addition of MRSI, is of incremental prognostic significance for patients with moderate and high risk tumors. MRI and MRSI may assist in surgical and radiation treatment planning, and posttreatment followup. In particular, the use of MRI to assist radiation treatment planning has been shown to improve outcome. Interventional MRI guided biopsy and therapy remain under investigation. Conclusions: Only MRI and MRSI allow combined structural and metabolic evaluation of prostate cancer location, aggressiveness and stage. MRI provides clinically and therapeutically relevant anatomical information. The technology remains in evolution, and continued advances in accuracy and use are likely.",
keywords = "Magnetic resonance imaging, Magnetic resonance spectroscopy, Prostatic neoplasms",
author = "Coakley, {Fergus V.} and Aliya Qayyum and John Kurhanewicz and Kantoff, {Philip W.} and Fergus Coakley and Carroll, {Peter R.} and Mack Roach and Smith, {Matthew R.} and Oh, {William K.}",
year = "2003",
month = "12",
doi = "10.1097/01.ju.0000094958.23276.c4",
language = "English (US)",
volume = "170",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "6 II",

}

TY - JOUR

T1 - Magnetic resonance imaging and spectroscopic imaging of prostate cancer

AU - Coakley, Fergus V.

AU - Qayyum, Aliya

AU - Kurhanewicz, John

AU - Kantoff, Philip W.

AU - Coakley, Fergus

AU - Carroll, Peter R.

AU - Roach, Mack

AU - Smith, Matthew R.

AU - Oh, William K.

PY - 2003/12

Y1 - 2003/12

N2 - Purpose: We describe the practical technical aspects of magnetic resonance spectroscopic imaging (MRSI), and summarize the current and potential future status of magnetic resonance imaging (MRI) and MRSI in the diagnosis, localization, staging, treatment planning and posttreatment followup of prostate cancer. Materials and Methods: Contemporary series of patients with prostate cancer evaluated by MRI and MRSI were reviewed, with particular respect to imaging accuracy as evaluated by histopathological correlation, and the relationship between MRI and MRSI and outcome. Results: MRI and MRSI have a limited role in prostate cancer diagnosis but may be helpful for patients with a high index of suspicion and negative initial biopsy. High specificity can be achieved for sextant localization of cancer when sextant biopsy, MRI and MRSI are all positive. Volumetric localization is of limited accuracy for tumors less than 0.5 cc. Staging by MRI, which is improved by the addition of MRSI, is of incremental prognostic significance for patients with moderate and high risk tumors. MRI and MRSI may assist in surgical and radiation treatment planning, and posttreatment followup. In particular, the use of MRI to assist radiation treatment planning has been shown to improve outcome. Interventional MRI guided biopsy and therapy remain under investigation. Conclusions: Only MRI and MRSI allow combined structural and metabolic evaluation of prostate cancer location, aggressiveness and stage. MRI provides clinically and therapeutically relevant anatomical information. The technology remains in evolution, and continued advances in accuracy and use are likely.

AB - Purpose: We describe the practical technical aspects of magnetic resonance spectroscopic imaging (MRSI), and summarize the current and potential future status of magnetic resonance imaging (MRI) and MRSI in the diagnosis, localization, staging, treatment planning and posttreatment followup of prostate cancer. Materials and Methods: Contemporary series of patients with prostate cancer evaluated by MRI and MRSI were reviewed, with particular respect to imaging accuracy as evaluated by histopathological correlation, and the relationship between MRI and MRSI and outcome. Results: MRI and MRSI have a limited role in prostate cancer diagnosis but may be helpful for patients with a high index of suspicion and negative initial biopsy. High specificity can be achieved for sextant localization of cancer when sextant biopsy, MRI and MRSI are all positive. Volumetric localization is of limited accuracy for tumors less than 0.5 cc. Staging by MRI, which is improved by the addition of MRSI, is of incremental prognostic significance for patients with moderate and high risk tumors. MRI and MRSI may assist in surgical and radiation treatment planning, and posttreatment followup. In particular, the use of MRI to assist radiation treatment planning has been shown to improve outcome. Interventional MRI guided biopsy and therapy remain under investigation. Conclusions: Only MRI and MRSI allow combined structural and metabolic evaluation of prostate cancer location, aggressiveness and stage. MRI provides clinically and therapeutically relevant anatomical information. The technology remains in evolution, and continued advances in accuracy and use are likely.

KW - Magnetic resonance imaging

KW - Magnetic resonance spectroscopy

KW - Prostatic neoplasms

UR - http://www.scopus.com/inward/record.url?scp=0242692689&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0242692689&partnerID=8YFLogxK

U2 - 10.1097/01.ju.0000094958.23276.c4

DO - 10.1097/01.ju.0000094958.23276.c4

M3 - Article

C2 - 14610414

AN - SCOPUS:0242692689

VL - 170

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 6 II

ER -